JN Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 94: 907-918, 2005. First published February 23, 2005; doi:10.1152/jn.00944.2004
0022-3077/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/2/907    most recent
00944.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (20)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haglund, M. M.
Right arrow Articles by Hochman, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haglund, M. M.
Right arrow Articles by Hochman, D. W.

TRANSLATIONAL PHYSIOLOGY

Furosemide and Mannitol Suppression of Epileptic Activity in the Human Brain

Michael M. Haglund1 and Daryl W. Hochman2

1Departments of Surgery (Neurosurgery) and Neurobiology and 2Surgery (Experimental) and Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina

Submitted 10 September 2004; accepted in final form 17 February 2005

Most research on basic mechanisms of epilepsy and the design of new antiepileptic drugs has focused on synaptic transmission or action potential generation. However, a number of laboratory studies have suggested that nonsynaptic mechanisms, such as modulation of electric field interactions via the extracellular space (ECS), might also contribute to neuronal hypersynchrony and epileptogenicity. To date, a role for nonsynaptic modulation of epileptic activity in the human brain has not been investigated. Here we studied the effects of molecules that modulate the volume and water content of the ECS on epileptic activity in patients suffering from neocortical and mesial temporal lobe epilepsy. Electrophysiological and optical imaging data were acquired from the exposed cortices of anesthetized patients undergoing surgical treatment for intractable epilepsy. Patients were given a single intravenous injection containing either 20 mg furosemide (a cation-chloride cotransporter antagonist) or 50 g mannitol (an osmolyte). Furosemide and mannitol both significantly suppressed spontaneous epileptic spikes and electrical stimulation-evoked epileptiform discharges in all subjects, completely blocking all epileptic activity in some patients without suppressing normal electroencephalographic activity. Optical imaging suggested that the spread of electrical stimulation-evoked activity over the cortex was significantly reduced by these treatments, but the magnitude of neuronal activation near the stimulating electrode was not diminished. These results suggest that nonsynaptic mechanisms play a critical role in modulating the epileptogenicity of the human brain. Furosemide and other drugs that modulate the ECS might possess clinically useful antiepileptic properties, while avoiding the side effects associated with the suppression of neuronal excitability.


Address for reprint requests and other correspondence: D. W. Hochman, Dept of Surgery, Duke University Medical Center, Box 3807, Durham, NC 27710 (E-mail: dhochman{at}duke.edu)




This article has been cited by other articles:


Home page
J. Neurosci.Home page
G. Huberfeld, L. Wittner, S. Clemenceau, M. Baulac, K. Kaila, R. Miles, and C. Rivera
Perturbed Chloride Homeostasis and GABAergic Signaling in Human Temporal Lobe Epilepsy
J. Neurosci., September 12, 2007; 27(37): 9866 - 9873.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Wake, M. Watanabe, A. J. Moorhouse, T. Kanematsu, S. Horibe, N. Matsukawa, K. Asai, K. Ojika, M. Hirata, and J. Nabekura
Early Changes in KCC2 Phosphorylation in Response to Neuronal Stress Result in Functional Downregulation
J. Neurosci., February 14, 2007; 27(7): 1642 - 1650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the The American Physiological Society.